UT Health San Antonio, University Hospital begin second phase of clinical trial for promising COVID-19 drug
May 13, 2020
Media contact: Rosanne Fohn, (210) 567-3026, fohn@uthscsa.edu SAN ANTONIO (May 11, 2020) — The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID. This second phase of […]
